CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- 4 Planned sale Chief Financial Officer sold 3,493 shares at an average $14.03 ($49,011)
- 4 Planned sale CEO and Chairman sold 3,600 shares at an average $14.09 ($50,706)
- 4 Planned sale Chief Financial Officer sold 107 shares at $13.99 ($1,497)
- 4 Planned sale CEO and Chairman sold 500 shares at $14.13 ($7,065)
- 4 Planned sale Chief Financial Officer sold 1,800 shares at an average $13.99 ($25,183)
- 4 Planned sale CEO and Chairman sold 1,300 shares at $14.01 ($18,213)
- 4 Planned sale Chief Financial Officer sold 12,400 shares at an average $14.05 ($174,175)
- 4 Planned sale CEO and Chairman sold 9,371 shares at an average $14.06 ($131,779)
- 4 Planned sale Chief Financial Officer sold 2,000 shares at an average $14.00 ($27,992)
- 4 Planned sale CEO and Chairman sold 5,029 shares at $13.99 ($70,356)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 4 · 69 filings